Kailera Therapeutics, Inc.
Kailera Therapeutics, Inc. scores highest on Torque (75) and lowest on Earnings (21). Its PosiPenta is 45.27 out of 100, around the middle of similar companies.
On the Penta Grid this week, Kailera Therapeutics, Inc. is Grid #376 of 836 in the Healthcare sector in United States, and Grid #2,388 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Kailera Therapeutics, Inc. | 45.27 | 36 | 21 | 35 | 75 | 59 |
| GeneDx Holdings Corp. | 38.32 | 9 | 53 | 42 | 40 | 49 |
| Omnicell, Inc. | 61.03 | 48 | 85 | 59 | 62 | 51 |
| UroGen Pharma Ltd. | 55.32 | 0 | 62 | 72 | 96 | 46 |
| ANI Pharmaceuticals, Inc. | 64.05 | 58 | 88 | 57 | 54 | 63 |
| Personalis, Inc. | 46.98 | 10 | 39 | 86 | 46 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.49 |
| P/B ratio | 1.30 |
EEarnings
| Trailing EPS | ₹-427.16 |
| Forward EPS | ₹-406.90 |
NNitro
| Price | 1065.54 |
| 52-week high | 2673.80 |
| 52-week low | 924.42 |
| Fall from 52-week high | 60.1% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | — |
| Market cap | ₹13,814 Cr |
| Insider holding | 8.91% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Kailera Therapeutics, Inc.'s PosiPenta score?
Kailera Therapeutics, Inc.'s PosiPenta is 45.27 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Kailera Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Kailera Therapeutics, Inc. is Grid #376 of 836 in the Healthcare sector in United States, and Grid #2,388 of 3,999 in United States.
Which PosiPenta pillar is strongest for Kailera Therapeutics, Inc.?
Torque (durability), with a score of 75 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Kailera Therapeutics, Inc.?
Earnings (growth), with a score of 21 out of 100: weaker than most similar companies.
Has Kailera Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.31 points, from 42.96 to 45.27.
PositoAI is for research and education only and is not investment advice.